A Phase II Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) as Conversion Therapy for Locally Advanced Pancreatic Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Locally Advanced Pancreatic Cancer With KRAS G12D Mutation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Jiangsu Province Hospital, Nanjing, China
Contact: Study coordinator (Jiang K Rong)